Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis.

PubWeight™: 5.57‹?› | Rank: Top 1%

🔗 View Article (PMID 12435258)

Published in JAMA on November 20, 2002

Authors

P J Devereaux1, Holger J Schünemann, Nikila Ravindran, Mohit Bhandari, Amit X Garg, Peter T-L Choi, Brydon J B Grant, Ted Haines, Christina Lacchetti, Bruce Weaver, John N Lavis, Deborah J Cook, David R S Haslam, Terrence Sullivan, Gordon H Guyatt

Author Affiliations

1: Depatment of Medicine, McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada L8N 3Z5. philipj@mcmaster.ca

Articles citing this

What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99

Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22

Using research to inform healthcare managers' and policy makers' questions: from summative to interpretive synthesis. Healthc Policy (2005) 3.12

What is the empirical evidence that hospitals with higher-risk adjusted mortality rates provide poorer quality care? A systematic review of the literature. BMC Health Serv Res (2007) 3.02

Payments for care at private for-profit and private not-for-profit hospitals: a systematic review and meta-analysis. CMAJ (2004) 2.76

Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ (2010) 2.37

A systematic review of studies comparing health outcomes in Canada and the United States. Open Med (2007) 2.26

Competition in a publicly funded healthcare system. BMJ (2007) 1.68

Globalization and risks to health. EMBO Rep (2004) 1.26

The effect of dialysis chains on mortality among patients receiving hemodialysis. Health Serv Res (2010) 1.18

Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. Health Serv Res (2006) 1.14

Reexploring differences among for-profit and nonprofit dialysis providers. Health Serv Res (2010) 1.02

Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol (2013) 1.00

The high costs of for-profit care. CMAJ (2004) 0.96

Effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneous coronary interventions. CMAJ (2006) 0.93

Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int (2014) 0.88

Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis. BMC Nephrol (2008) 0.88

Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation. BMC Nephrol (2014) 0.86

A systematic review of the impact of center volume in dialysis. BMC Res Notes (2015) 0.86

Nephrologist caseload and hemodialysis patient survival in an urban cohort. J Am Soc Nephrol (2013) 0.85

Regional differences in dialysis care and mortality among American Indians and Alaska Natives. J Am Soc Nephrol (2011) 0.85

Quality of care in profit vs not-for-profit dialysis centers. JAMA (2003) 0.84

Can a learning-disabled nation learn healthcare lessons from abroad? Healthc Policy (2007) 0.84

Characteristics and performance of minority-serving dialysis facilities. Health Serv Res (2013) 0.82

Does ownership matter? An overview of systematic reviews of the performance of private for-profit, private not-for-profit and public healthcare providers. PLoS One (2014) 0.81

Quality of care in profit vs not-for-profit dialysis centers. JAMA (2003) 0.79

Observational Evidence of For-Profit Delivery and Inferior Nursing Home Care: When Is There Enough Evidence for Policy Change? PLoS Med (2016) 0.78

Quality of care in profit vs not-for-profit dialysis centers. JAMA (2003) 0.78

Organizational status of dialysis facilities and patient outcome: does higher injectable medication use mediate increased mortality? Health Serv Res (2012) 0.78

Variation in dialysis quality measures by facility, neighborhood, and region. Med Care (2013) 0.77

Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities. Clin J Am Soc Nephrol (2014) 0.77

Payments and quality of care in private for-profit and public hospitals in Greece. BMC Health Serv Res (2011) 0.77

Sustaining canadian medicare. Healthc Policy (2008) 0.75

Quality of care in profit vs not-for-profit dialysis centers. JAMA (2003) 0.75

Differences in quality of life of hemodialysis patients between dialysis centers. Qual Life Res (2011) 0.75

Mortality, length of stay, and inpatient charges for heart failure patients at public versus private hospitals in South Korea. Yonsei Med J (2015) 0.75

Do health outcomes vary by profit status of hemodialysis units? Clin J Am Soc Nephrol (2013) 0.75

A qualitative study of diverse providers' behaviour in response to commissioners, patients and innovators in England: research protocol. BMJ Open (2016) 0.75

Kickbacks and self-referral. CMAJ (2004) 0.75

For-profit status and industry evolution in health care markets: evidence from the dialysis industry. Int J Health Econ Manag (2016) 0.75

Articles by these authors

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39

Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA (2009) 13.00

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71

Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med (2008) 11.00

GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02

Randomized trials stopped early for benefit: a systematic review. JAMA (2005) 8.43

Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA (2002) 8.30

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med (2002) 7.87

Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32

Going from evidence to recommendations. BMJ (2008) 7.30

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20

Knowledge translation of research findings. Implement Sci (2012) 7.17

What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99

A guide for the design and conduct of self-administered surveys of clinicians. CMAJ (2008) 6.72

High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med (2013) 6.56

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54

Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA (2008) 6.39

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ (2009) 6.27

Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21

Use of evidence in WHO recommendations. Lancet (2007) 6.12

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol (2010) 5.78

Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology (2013) 5.69

Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med (2012) 5.67

Parallel payers and preferred access: how Canada's Workers' Compensation Boards expedite care for injured and ill workers. Healthc Pap (2008) 5.62

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

A Trial of Wound Irrigation in the Initial Management of Open Fracture Wounds. N Engl J Med (2015) 5.28

Helping patients follow prescribed treatment: clinical applications. JAMA (2002) 5.18

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Genome sequence of Silicibacter pomeroyi reveals adaptations to the marine environment. Nature (2004) 5.00

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ (2013) 4.90

A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. CMAJ (2002) 4.84

Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58

Effects of policy options for human resources for health: an analysis of systematic reviews. Lancet (2008) 4.55

Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2002) 4.52

Internet versus mailed questionnaires: a randomized comparison (2). J Med Internet Res (2004) 4.45

The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med (2009) 4.41

Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med (2013) 4.35

Need for expertise based randomised controlled trials. BMJ (2005) 4.34

Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med (2006) 4.32

An observational study of orthopaedic abstracts and subsequent full-text publications. J Bone Joint Surg Am (2002) 4.25

Quality councils as health system performance and accountability mechanisms: the Cancer Quality Council of Ontario experience. Healthc Pap (2006) 4.14

Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96

Global trends in the rates of living kidney donation. Kidney Int (2009) 3.81

Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA (2009) 3.81

A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol (2008) 3.75

When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70

The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62

GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol (2010) 3.60

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58

Physicians' and patients' choices in evidence based practice. BMJ (2002) 3.57

GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ (2010) 3.54

Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53

A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int (2012) 3.47

Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev (2011) 3.44

GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44

The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med (2013) 3.43

Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ (2009) 3.39

Family satisfaction with care in the intensive care unit: results of a multiple center study. Crit Care Med (2002) 3.36

Barriers to full-text publication following presentation of abstracts at annual orthopaedic meetings. J Bone Joint Surg Am (2003) 3.36